Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Feb 2026, Mar 2026 and May 2026.
- Largest single sale: $70K (2,772 shares) of Arcutis Biotherapeutics, Inc. on Mar 2, 2026. Filing
- Last sale before this period: Aug 4, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | May 7, 2025 | May 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 11, 2026, Arcutis Biotherapeutics, Inc.: sold 435 shares for $9K, under a disclosed plan. 1 filing: 1
- May 4, 2026, Arcutis Biotherapeutics, Inc.: sold 1,341 shares for $32K, under a disclosed plan. 1 filing: 1
- Mar 2, 2026, Arcutis Biotherapeutics, Inc.: sold 2,853 shares for $72K, under a disclosed plan. 1 filing: 1
- Feb 27, 2026, Arcutis Biotherapeutics, Inc.: 27,000 shares granted. 1 filing: 1
- Feb 2, 2026, Arcutis Biotherapeutics, Inc.: sold 1,320 shares for $34K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.